About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,589 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,589 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4241-4260 of 6,589 trials

CompletedPhase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving RadioimmunotherapyThis will be a multi-center, Phase I, dose-escalation study of bortezomib in combination with 131I-tositumomab in patients with relapsed non-Hodgkin's lymphoma.NCT00777114·Ann Arbor, Michigan and 1 other CompletedA Prospective Cohort Study of Occupational Exposures and Cancer Risk Among WomenA prospective cohort study is proposed to evaluate occupational and environmental risk factors for cancer among women in Shanghai, China.NCT00342004·Shanghai

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

WithdrawnReduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For LymphomaThis research study is assessing the feasibility of reduced intensity allogeneic hematopoietic stem cell transplantation (HSCT) as a possible treatment for relapsed / refractory…NCT02724904·Boston, Massachusetts and 1 other

CompletedA Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]This is a retrospective study in adult patients with cirrhosis and grade 3 or 4 HE (West Haven Criteria) to evaluate the effectiveness and safety of lactulose retention enema in…NCT02377947·Gurgaon and 2 others

UnknownRituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell LymphomaRituximab (R) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) combination is considered as the new gold standard for the first-line treatment of elderly…NCT01181999·Jeollanam-do

TerminatedR-CHOP-B Bevacizumab for Diffuse Large B Cell LymphomaThis study evaluates the use of the standard treatment R-CHOP plus the anti-VEGF drug, bevacizumab and whether this treatment is feasible in patients with stage II, III and IV…NCT00788606·Sutton, Surrey and 1 other

CompletedIpilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell LymphomaThis partially randomized phase I trial studies the side effects and best dose of ipilimumab when given together with rituximab in treating patients with B-cell lymphoma that has…NCT01729806·Duarte, California and 6 others

Active not recruitingAcalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCLThis is a multi-arm phase 2 study to evaluate the preliminary evidence of efficacy and safety of the combination of acalabrutinib, lenalidomide and rituximab (ALR) and…NCT03863184·New York, New York

RecruitingZanubrutinib and Tafasitamab in Mantle Cell LymphomaThe main purpose of this study to find the ideal dose for the combination treatment of Zanubrutinib and Tafasitamab in patients with mantle cell lymphoma.NCT06029309·Miami, Florida

UnknownGPED Regimen for Relapsed/Refractory or Advanced ENKTCLThe purpose of this study is to evaluate the efficacy and safety of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in the treatment of Relapsed/Refractory or…NCT04405375·Beijing

Not yet recruitingR-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS LymphomaThis is a prospective, open-label, multicenter, randomized controlled study in treatment-naive patients with primary central nervous system lymphoma (PCNSL, DLBCL type).NCT07764601·Changzhou, Jiangsu and 4 others

TerminatedStudy of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary SyndromeThe purpose of this study is to determine the efficacy of the drug, HuMax-CD4, in patients with mycosis fungoides(MF) and sezary syndrome who are intolerant to or do not respond…NCT00127881·Birmingham, Alabama and 34 others

CompletedIdentifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric OncologyThis research trial studies the use of clinical practice guidelines by pediatric oncology healthcare providers in order to identify, understand, and overcome barriers to them.NCT02847130·Oakland, California and 32 others

UnknownCord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid MalignanciesThis is a single-center, open-label, single-arm study to evaluate the primary safety and efficacy of anti-CD19 chimeric antigen receptor(CAR)-modified NK cells(CAR-NK-CD19) in…NCT04796675·Wuhan, Hubei

RecruitingEpcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell LymphomaThis phase II trial tests how well the combination of epcoritamab and lenalidomide work in treating patients with immunodeficiency-related large B-cell lymphoma that does not…NCT06723457·Chicago, Illinois

CompletedRituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's LymphomaConventional therapy is effective for diffuse aggressive lymphomas and low grade lymphomas, but is limited by relapse occurs in 40 to 50% of subjects.NCT00225212·Stanford, California

CompletedNMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRATIONALE: Giving low doses of chemotherapy before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells.NCT00053989·Buffalo, New York

Active not recruitingVenetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaThis phase II trial studies how well venetoclax and acalabrutinib work in treating patients with mantle cell lymphoma that did not respond to previous treatment or has come back.NCT03946878·Houston, Texas

CompletedThe Effect of Patient-Family Communication Via Audio RecordingThe study was conducted as a randomized controlled blinded study. The sample consisted of 55 patient relatives (27 in the experimental group and 28 in the control group).NCT06627725·Ordu

CompletedEarly Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)Newly diagnosed DLCL patients will have baselne FDG-PET as part of initial staging (PET-1). Patients will then undergo 2 cycles of chemotherapy with R/CHOP.NCT00754117·New York, New York

PreviousPage 213 of 330Next